Kimia Biosciences Share Price Live
Live Kimia Biosciences Share Price Chart
Kimia Biosciences Performance
Days Range
| Previous Close | ₹32.60 |
|---|---|
| Open | ₹32.5 |
| Volume | 4,521 |
| Day's Range | ₹31.70 - ₹33.08 |
|---|---|
| 52W Range | ₹26.09 - ₹86.85 |
| Market Cap | ₹154.24 Cr |
Kimia Biosciences Fundamentals
| ROCE(TTM) | 33.57 |
|---|---|
| P/E Ratio (TTM) | 18.84 |
| P/B Ratio | 13.31 |
| Industry P/E | 40.17 |
| Debt to Equity | 3.11 |
| ROE | 70.62 |
| EPS (TTM) | 1.73 |
| Dividend Yield | 0 |
| Book Value | 2.45 |
| Face Value | 1 |
| ROCE(TTM) | 33.57 |
|---|---|
| P/E Ratio (TTM) | 18.84 |
| P/B Ratio | 13.31 |
| Industry P/E | 40.17 |
| Debt to Equity | 3.11 |
| ROE | 70.62 |
|---|---|
| EPS (TTM) | 1.73 |
| Dividend Yield | 0 |
| Book Value | 2.45 |
| Face Value | 1 |
Kimia Biosciences Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 30.10 | 38.24 | 23.58 | 34.00 |
| Expenses | 25.92 | 30.94 | 21.99 | 32.45 |
| Profit before tax | 3.60 | 6.34 | 0.69 | 0.95 |
| Operating Profit | 4.57 | 1.99 | 0.60 | 1.02 |
| Net Profit | 4.57 | 1.99 | 0.60 | 1.02 |
| ESP in Rs | 0.97 | 0.42 | 0.13 | 0.21 |
Kimia Biosciences Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% |
| Public | 24.68% | 24.68% | 24.68% | 24.68% | 24.68% |
About Kimia Biosciences
Incorporated in Sep.'93, Laurel Organics (formerly Dolphin Organics) is promoted by A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95.
The company proposes to run plant more efficiently provided the financial institution provided suitable and required assistance. It also plans to revive its operational activity to normal capacity before March' 99.
During the 1998-99, the company has become a sick industrial units.
Parent Organisation
Indian Private
Managing Director
Sameer Goel
Founded
1993
NSE Symbol
Top Mutual Funds Invested in Kimia Biosciences Share
Top Mutual Funds Invested in Kimia Biosciences Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,794.1 -13.10 (-0.72%) | ₹4,33,535.84 | 1,548.0 - 1,910.0 |
| Divis Laboratories Ltd | 6,419.0 -11.00 (-0.17%) | ₹1,70,753.37 | 4,955.0 - 7,071.5 |
| Torrent Pharmaceuticals Ltd | 3,794.8 -4.20 (-0.11%) | ₹1,28,644.10 | 2,886.45 - 3,882.2 |
| Cipla Ltd | 1,516.4 4.10 (0.27%) | ₹1,22,143.09 | 1,335.0 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,278.9 5.40 (0.42%) | ₹1,06,244.27 | 1,020.0 - 1,405.9 |
| Lupin Ltd | 2,114.2 32.40 (1.56%) | ₹95,030.14 | 1,795.2 - 2,402.9 |
Popular stocks
Kimia Biosciences Ltd FAQs
What is the share price of Kimia Biosciences Ltd (Kimia Biosciences Ltd) shares?
Kimia Biosciences Ltd (Kimia Biosciences Ltd) share price as of December 11, 2025, on NSE is Rs 32.57 (NSE) and Rs 32.57 (BSE) on BSE.
Can I buy Kimia Biosciences Ltd (Kimia Biosciences Ltd) from Angel One?
Yes, You can buy Kimia Biosciences Ltd (Kimia Biosciences Ltd) shares by opening a Demat account with Angel One.
How do I buy Kimia Biosciences Ltd (Kimia Biosciences Ltd) from Angel One?
Kimia Biosciences Ltd (Kimia Biosciences Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Kimia Biosciences Ltd (Kimia Biosciences Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Kimia Biosciences Ltd (Kimia Biosciences Ltd) shares.
1. Direct investment: You can buy Kimia Biosciences Ltd (Kimia Biosciences Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Kimia Biosciences Ltd (Kimia Biosciences Ltd) shares.
